Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model
Science Translational Medicine · 03.04.2024 · 16 (741)
DOI: 10.1126/scitranslmed.adj9052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 03.04.2024. Verfasst von Jinchao Hou und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Microglia, Alzheimer Disease. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Microglia help limit the progression of Alzheimer’s disease (AD) by constraining amyloid-β (Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals delivered by distinct cell surface receptors. Human leukocyte Ig-like receptor B4 (LILRB4) is an inhibitory receptor of the immunoglobulin (Ig) superfamily that is expressed on myeloid cells and recognizes apolipoprotein E (ApoE) among other ligands. Here, we find that LILRB4 is highly expressed in the microglia of patients with AD. Using mice that accumulate Aβ and carry a transgene encompassing a portion of the LILR region that includes LILRB4 , we corroborated abundant LILRB4 expression in microglia wrapping around Aβ plaques. Systemic treatment of these mice with an anti-human LILRB4 monoclonal antibody (mAb) reduced Aβ load, mitigated some Aβ-related behavioral abnormalities, enhanced microglia activity, and attenuated expression of interferon-induced genes. In vitro binding experiments established that human LILRB4 binds both human and mouse ApoE and that anti-human LILRB4 mAb blocks such interaction. In silico modeling, biochemical, and mutagenesis analyses identified a loop between the two extracellular Ig domains of LILRB4 required for interaction with mouse ApoE and further indicated that anti-LILRB4 mAb may block LILRB4-mApoE by directly binding this loop. Thus, targeting LILRB4 may be a potential therapeutic avenue for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO 63110, USA.
- Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University in St. Louis, St. Louis, MO 63110, USA.
- Department of Radiology, Washington University in St. Louis, St. Louis, MO 63110, USA.
- Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Chemistry, Washington University in St. Louis, St. Louis, MO 63110, USA.
ORCID-Profile: Jinchao Hou, Yun Chen, Zhangying Cai, Gyu Seong Heo, Carla M Yuede, Zuoxu Wang, Kent Lin, Fareeha Saadi, Tihana Trsan, Aivi T Nguyen, Eleni Constantopoulos, Rachel A Larsen, Yiyang Zhu, Nicole D Wagner, Dian Li, Yingyue Zhou, Shoutang Wang, Susan Gilfillan, Michael L Gross, Simone Brioschi, Yongjian Liu, David M Holtzman, Marco Colonna
Förderung
- NIA NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Hou, J., Chen, Y., Cai, Z., Heo, G. S., Yuede, C. M., Wang, Z., Lin, K., Saadi, F., Trsan, T., Nguyen, A. T., Constantopoulos, E., Larsen, R. A., Zhu, Y., Wagner, N. D., McLaughlin, N., Kuang, X. C., Barrow, A. D., Li, D., Zhou, Y., …, & Colonna, M. (2024). Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model. Science Translational Medicine, 16(741). https://doi.org/10.1126/scitranslmed.adj9052
Vancouver
Hou J, Chen Y, Cai Z, Heo GS, Yuede CM, Wang Z, et al. Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model. Science Translational Medicine. 2024;16(741). doi:10.1126/scitranslmed.adj9052
BibTeX
@article{Hou2024,
author = {Hou, Jinchao and Chen, Yun and Cai, Zhangying and Heo, Gyu Seong and Yuede, Carla M and Wang, Zuoxu and Lin, Kent and Saadi, Fareeha and Trsan, Tihana and Nguyen, Aivi T and Constantopoulos, Eleni and Larsen, Rachel A and Zhu, Yiyang and Wagner, Nicole D and McLaughlin, Nolan and Kuang, Xinyi Cynthia and Barrow, Alexander D and Li, Dian and Zhou, Yingyue and Wang, Shoutang and Gilfillan, Susan and Gross, Michael L and Brioschi, Simone and Liu, Yongjian and Holtzman, David M and Colonna, Marco},
title = {Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model},
journal = {Science Translational Medicine},
year = {2024},
volume = {16},
number = {741},
doi = {10.1126/scitranslmed.adj9052}
}
EUVIMED